Similar articles

• Neoral C2 monitoring in solid organ transplantation.

  Levy GA. Levy GA. Transplant Proc. 2004 Mar;36(2 Suppl):392S-395S. doi: 10.1016/j.transproceed.2004.01.017. Transplant Proc. 2004. PMID: 15041373 Review. No abstract available.
• Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.

  Banner NR, David OJ, Leaver N, Davis J, Breen J, Johnston A, Yacoub MH. Banner NR, et al. Transpl Int. 2002 Dec;15(12):649-54. doi: 10.1007/s00147-002-0491-0. Epub 2002 Nov 22. Transpl Int. 2002. PMID: 12478413
• Cyclosporine neoral pharmacokinetics in kidney and heart transplant patients.

  Schiavelli R, Sgrosso JL, Sabbatiello R, Castro C, Ahualli L, Pattin M, Vazquez MC. Schiavelli R, et al. Transplant Proc. 1996 Dec;28(6):3343-4. Transplant Proc. 1996. PMID: 8962299 No abstract available.
• Evolution of the therapeutic drug monitoring of cyclosporine.

  Citterio F. Citterio F. Transplant Proc. 2004 Mar;36(2 Suppl):420S-425S. doi: 10.1016/j.transproceed.2004.01.054. Transplant Proc. 2004. PMID: 15041378 Review.
• A limited sampling strategy for the estimation of 12-hour cyclosporine neoral area under the curve in Chinese cardiac transplant recipients.

  Wang CH, Ko WJ, Chou NK, Wang SS. Wang CH, et al. Transplant Proc. 2004 Oct;36(8):2390-2. doi: 10.1016/j.transproceed.2004.08.025. Transplant Proc. 2004. PMID: 15561259